This year's Bio International Convention attracted more than 15,000 attendees, among them an army of economic developers and elected officials hoping to secure investments into the sector. Michal Kaczmarski asked representatives why investors should bet on their locations and whether they see emerging markets as a source of opportunities or competition.

Hopes are high that the a more business-friendly India will emerge under the stewardship of new prime minister Narendra Modi. But the FDI fortunes of India’s states look to remain disparate until policies and regulations are better coordinated.

Costa Rica's new president, Luis Guillermo Solis, has wasted no time in hitting the investment trail. During his first visit to the US, he tells Michal Kaczmarski why inward investment is so important and explains his strategy for making Costa Rica a hub for high-tech companies.

For biopharmaceutical companies entering Europe, the Belgian region of Wallonia is proving particularly popular. One reason for this is the service provided by the region’s export and investment agency, AWEX, finds Wendy Atkins

Widely considered the Holy Grail of inward investment, the biotech industry is perceived as possessing relative immunity to economic woes. With such potentially high rewards at stake, more and more destinations are trying to gain a foothold in the sector.

The Lower Saxony region in Germany is home to the world's largest exhibition hall and an impressive biotech cluster, meaning that the region is becoming a must-visit destination for numerous big names in the industry.

The US state of Delaware is emerging from its post-industrial decline to embrace investment opportunities and make the most of its geographical location, says its governor, Jack Markell.

Seemingly every FDI-hungry location in the world is eyeing the automotive and biotech sectors, but by focusing on the SME supply chain, the east German city of Leipzig is managing to excel in both areas.